Literature DB >> 29016852

Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2.

James M Dell'Orco1, Stefan M Pulst2, Vikram G Shakkottai1,3.   

Abstract

Alterations in Purkinje neuron firing often accompany ataxia, but the molecular basis for these changes is poorly understood. In a mouse model of spinocerebellar ataxia type 2 (SCA2), a progressive reduction in Purkinje neuron firing frequency accompanies cell atrophy. We investigated the basis for altered Purkinje neuron firing in SCA2. A reduction in the expression of large-conductance calcium-activated potassium (BK) channels and Kv3.3 voltage-gated potassium channels accompanies the inability of Purkinje neurons early in disease to maintain repetitive spiking. In association with prominent Purkinje neuron atrophy, repetitive spiking is restored, although at a greatly reduced firing frequency. In spite of a continued impairment in spike repolarization and a persistently reduced BK channel mediated afterhyperpolarization (AHP), repetitive spiking is maintained, through the increased activity of barium-sensitive potassium channels, most consistent with inwardly rectifying potassium (Kir) channels. Increased activity of Kir channels results in the generation of a novel AHP not seen in wild-type Purkinje neurons that also accounts for the reduced firing frequency late in disease. Homeostatic changes in Purkinje neuron morphology that help to preserve repetitive spiking can also therefore have deleterious consequences for spike frequency. These results suggest that the basis for spiking abnormalities in SCA2 differ depending on disease stage, and interventions targeted towards correcting potassium channel dysfunction in ataxia need to be tailored to the specific stage in the degenerative process.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29016852      PMCID: PMC5886219          DOI: 10.1093/hmg/ddx281

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  39 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Discharge of Purkinje and cerebellar nuclear neurons during rapidly alternating arm movements in the monkey.

Authors:  W T Thach
Journal:  J Neurophysiol       Date:  1968-09       Impact factor: 2.714

3.  Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.

Authors:  Michael F Waters; Natali A Minassian; Giovanni Stevanin; Karla P Figueroa; John P A Bannister; Dagmar Nolte; Allan F Mock; Virgilio Gerald H Evidente; Dominic B Fee; Ulrich Müller; Alexandra Dürr; Alexis Brice; Diane M Papazian; Stefan M Pulst
Journal:  Nat Genet       Date:  2006-02-26       Impact factor: 38.330

4.  Mechanism of Ba(2+) block of a mouse inwardly rectifying K+ channel: differential contribution by two discrete residues.

Authors:  N Alagem; M Dvir; E Reuveny
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

5.  Disruption of the olivo-cerebellar circuit by Purkinje neuron-specific ablation of BK channels.

Authors:  Xiaowei Chen; Yury Kovalchuk; Helmuth Adelsberger; Horst A Henning; Matthias Sausbier; Georg Wietzorrek; Peter Ruth; Yosef Yarom; Arthur Konnerth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

6.  Pharmacological characterization of a non-inactivating outward current observed in mouse cerebellar Purkinje neurones.

Authors:  Trevor Bushell; Catherine Clarke; Alistair Mathie; Brian Robertson
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

7.  Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency.

Authors:  M Sausbier; H Hu; C Arntz; S Feil; S Kamm; H Adelsberger; U Sausbier; C A Sailer; R Feil; F Hofmann; M Korth; M J Shipston; H-G Knaus; D P Wolfer; C M Pedroarena; J F Storm; P Ruth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-11       Impact factor: 11.205

8.  FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons.

Authors:  Vikram G Shakkottai; Maolei Xiao; Lin Xu; Michael Wong; Jeanne M Nerbonne; David M Ornitz; Kelvin A Yamada
Journal:  Neurobiol Dis       Date:  2008-10-01       Impact factor: 5.996

9.  Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia.

Authors:  Vikram G Shakkottai; Chin-hua Chou; Salvatore Oddo; Claudia A Sailer; Hans-Günther Knaus; George A Gutman; Michael E Barish; Frank M LaFerla; K George Chandy
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

10.  Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.

Authors:  James M Dell'Orco; Aaron H Wasserman; Ravi Chopra; Melissa A C Ingram; Yuan-Shih Hu; Vikrant Singh; Heike Wulff; Puneet Opal; Harry T Orr; Vikram G Shakkottai
Journal:  J Neurosci       Date:  2015-08-12       Impact factor: 6.167

View more
  26 in total

Review 1.  Emerging connections between cerebellar development, behaviour and complex brain disorders.

Authors:  Aaron Sathyanesan; Joy Zhou; Joseph Scafidi; Detlef H Heck; Roy V Sillitoe; Vittorio Gallo
Journal:  Nat Rev Neurosci       Date:  2019-05       Impact factor: 34.870

2.  Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7.

Authors:  Colleen A Stoyas; David D Bushart; Pawel M Switonski; Jacqueline M Ward; Akshay Alaghatta; Mi-Bo Tang; Chenchen Niu; Mandheer Wadhwa; Haoran Huang; Alex Savchenko; Karim Gariani; Fang Xie; Joseph R Delaney; Terry Gaasterland; Johan Auwerx; Vikram G Shakkottai; Albert R La Spada
Journal:  Neuron       Date:  2019-12-16       Impact factor: 17.173

Review 3.  Spinocerebellar ataxias: prospects and challenges for therapy development.

Authors:  Tetsuo Ashizawa; Gülin Öz; Henry L Paulson
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

Review 4.  Ion channel dysfunction in cerebellar ataxia.

Authors:  David D Bushart; Vikram G Shakkottai
Journal:  Neurosci Lett       Date:  2018-02-05       Impact factor: 3.046

5.  Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia.

Authors:  Ravi Chopra; Aaron H Wasserman; Stefan M Pulst; Chris I De Zeeuw; Vikram G Shakkottai
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

6.  Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.

Authors:  Hayley S McLoughlin; Lauren R Moore; Ravi Chopra; Robert Komlo; Megan McKenzie; Kate G Blumenstein; Hien Zhao; Holly B Kordasiewicz; Vikram G Shakkottai; Henry L Paulson
Journal:  Ann Neurol       Date:  2018-08-06       Impact factor: 10.422

Review 7.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

8.  ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease.

Authors:  Vladimir A Martínez-Rojas; Aura M Jiménez-Garduño; Daniela Michelatti; Laura Tosatto; Marta Marchioretto; Daniele Arosio; Manuela Basso; Maria Pennuto; Carlo Musio
Journal:  J Mol Neurosci       Date:  2020-08-28       Impact factor: 3.444

9.  Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1.

Authors:  Ravi Chopra; David D Bushart; John P Cooper; Dhananjay Yellajoshyula; Logan M Morrison; Haoran Huang; Hillary P Handler; Luke J Man; Warunee Dansithong; Daniel R Scoles; Stefan M Pulst; Harry T Orr; Vikram G Shakkottai
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

Review 10.  Polyglutamine Repeats in Neurodegenerative Diseases.

Authors:  Andrew P Lieberman; Vikram G Shakkottai; Roger L Albin
Journal:  Annu Rev Pathol       Date:  2018-08-08       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.